A research conducted by a team from Brigham and Women’s Hospital (BWH) indicated that bone-morphogenetic protein (BMP), used in 25% of spinal fusion surgeries, lead to a higher rate of complications in certain types of fusions as well as greater hospital charges, as compared to fusions that do not use BMP. The primary increase was seen in wound-related complications and dysphagia or hoarseness.